Cargando…

Experience with ospemifene in a patient with vulvovaginal atrophy and dyslipidemia: a case study

The changes that occur in sex hormone levels, body composition, and lipid/lipoprotein levels during the menopause transition, together with vascular remodeling, increase the risk of cardiovascular disease (CVD) in postmenopausal women. Any treatments prescribed for concomitant conditions during meno...

Descripción completa

Detalles Bibliográficos
Autor principal:	Rodríguez, Silvia Pilar González
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337589/ https://www.ncbi.nlm.nih.gov/pubmed/32670379 http://dx.doi.org/10.7573/dic.2020-3-5

Ejemplares similares

Experience with ospemifene in patients with vulvovaginal atrophy treated with laser therapy: case studies
por: Salcedo, Félix Lugo, et al.
Publicado: (2020)

Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy
por: Shin, Jae Jun, et al.
Publicado: (2017)

Experience with ospemifene in patients with vulvar and vaginal atrophy: case studies with bone marker profiles
por: del Carmen Pingarrón Santofimia, María, et al.
Publicado: (2020)

Experience with ospemifene in patients with vulvar and vaginal atrophy and associated sexual dysfunction: case studies
por: López, Ana Rosa Jurado, et al.
Publicado: (2020)

Experience with ospemifene in patients with vulvar and vaginal atrophy and urinary incontinence: case studies
por: Blanco, Zuramis Estrada, et al.
Publicado: (2020)

Experience with ospemifene in patients with vulvar and vaginal atrophy and a history of breast cancer: case studies
por: Lilue, Mariella, et al.
Publicado: (2020)

Ospemifene May Not Treat Vulvar Atrophy: A Report of Two Cases
por: Goldstein, Andrew T., et al.
Publicado: (2016)

Ospemifene for vulvar and vaginal atrophy: an overview
por: Palacios, Santiago
Publicado: (2020)

Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis
por: Simon, James A., et al.
Publicado: (2023)

The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy
por: Nappi, R. E., et al.
Publicado: (2015)

Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy
por: Bruyniks, N., et al.
Publicado: (2016)

Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use
por: Cagnacci, Angelo, et al.
Publicado: (2020)

Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy
por: Goldstein, S. R., et al.
Publicado: (2014)

Clinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophy
por: Palacios, Santiago, et al.
Publicado: (2016)

Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast
por: Soe, Lin H, et al.
Publicado: (2013)

Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause
por: Wurz, Gregory T, et al.
Publicado: (2014)

Effect of Ospemifene on Densitometric and Plasma Bone Metabolism Biomarkers in Postmenopausal Women Reporting Vulvar and Vaginal Atrophy (VVA)
por: Maffei, Silvia, et al.
Publicado: (2022)

Update on alternative therapies for vulvovaginal atrophy
por: Chollet, Janet A
Publicado: (2011)

Hormonal Approach for Postmenopausal Vulvovaginal Atrophy
por: Costa, Ana Paula Ferreira, et al.
Publicado: (2021)

Use of Moisturizers and Lubricants for Vulvovaginal Atrophy
por: Sarmento, Ayane Cristine Alves, et al.
Publicado: (2021)

Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy
por: Parish, Sharon J, et al.
Publicado: (2013)

Early Effect of 0.005% Estriol Vaginal Gel on Symptoms and Signs of Vulvovaginal Atrophy
por: Lázaro-Carrasco de la Fuente, Jesús, et al.
Publicado: (2022)

Impact Of Vulvovaginal Atrophy Of Menopause In Spanish Women: Prevalence And Symptoms According To The EVES Study
por: Palacios, Santiago, et al.
Publicado: (2019)

Effect of Vitamin D Supplement on Vulvovaginal Atrophy of the Menopause
por: Kamronrithisorn, Thawinee, et al.
Publicado: (2020)

Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial
por: Constantine, G., et al.
Publicado: (2015)

Clinical Efficacy of Hormonal and Nonhormonal Agents in the Treatment of Vulvovaginal Atrophy
por: Ilhan, Gokcen, et al.
Publicado: (2021)

New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review
por: Benini, Vittoria, et al.
Publicado: (2022)

Vulvovaginal pyoderma gangrenosum in association with rituximab
por: Maloney, Catherine, et al.
Publicado: (2018)

Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
por: Grant, Leah M., et al.
Publicado: (2022)

A rare case of benign vulvovaginal leiomyoma: Case report and literature review
por: Ashraf Muhammed, Paxshan, et al.
Publicado: (2022)

Effects of topical estrogen therapy on the vaginal microcirculation in women with vulvovaginal atrophy
por: Diedrich, Chantal M., et al.
Publicado: (2019)

Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats
por: Ismail, Nur Hilwani, et al.
Publicado: (2023)

Risk of venous thromboembolism among women receiving ospemifene: a comparative observational study
por: Nordstrom, Beth L., et al.
Publicado: (2022)

Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women
por: Nappi, Rossella E., et al.
Publicado: (2019)

Erosive Vulvovaginitis Associated With Borrelia burgdorferi Infection
por: Fesler, Melissa C., et al.
Publicado: (2019)

Experience With a Non-Hormonal Centella Asiatica, Hyaluronic Acid and Prebiotic-Based Vaginal Gel in Women With Recurrent Vulvovaginal Candidiasis: Case Studies
por: Amorós, Manuela, et al.
Publicado: (2023)

Vulvovaginal Infralevator Haematoma Mimicking the Second Stage of Labour
por: Awoleke, J. O., et al.
Publicado: (2017)

First report of Vulvovaginitis due to Cryptococcus magnus in Iran
por: Ghajari, Ali, et al.
Publicado: (2018)

Endometrial safety of ospemifene: results of the phase 2/3 clinical development program
por: Constantine, Ginger D., et al.
Publicado: (2015)

Vulvovaginal myeloid sarcoma with massive pelvic floor infiltration: A case report and review of literature
por: Wang, Jia-Xi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_og7bi8no0qknse5ffavo0kce5u